Study summary

This clinical research study is investigating if bempedoic acid can reduce cholesterol and the risk of cardiovascular disease in patients who are intolerant to statins.

Half of the patients in the study will be given bempedoic acid, the other half will be given a placebo. They will not know which they are taking.

We will monitor your cholesterol levels throughout the trial and see if this medication reduces the number of heart attacks, strokes, heart-related surgery, hospital admissions and cholesterol-related deaths. 

Am I eligible for the study?

You may only enter into this study if you meet specific criteria outlined by our research team. You can apply to join the trial if you:

• Are 18 years of age or older
• Have a history of, or are at high risk for cardiovascular disease (CVD)
• Are statin intolerant (have not been able to tolerate two or more statins)

If you meet these criteria, our research team will decide whether you are eligible for the study during the screening process.

Qualified participants will receive all study medication and study-related care from a dedicated team of medical staff at no cost.

Filling out this survey does not obligate you to take part in the trial.